Cargando…
Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248092/ https://www.ncbi.nlm.nih.gov/pubmed/36375041 http://dx.doi.org/10.1182/bloodadvances.2022008968 |
| _version_ | 1785055297046315008 |
|---|---|
| author | Sharma, Parth Saksena, Annapurna Diaz, Adolfo Pang, Yifan Desai, Parth |
| author_facet | Sharma, Parth Saksena, Annapurna Diaz, Adolfo Pang, Yifan Desai, Parth |
| author_sort | Sharma, Parth |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10248092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102480922023-06-09 Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis Sharma, Parth Saksena, Annapurna Diaz, Adolfo Pang, Yifan Desai, Parth Blood Adv Research Letter The American Society of Hematology 2022-11-16 /pmc/articles/PMC10248092/ /pubmed/36375041 http://dx.doi.org/10.1182/bloodadvances.2022008968 Text en Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Sharma, Parth Saksena, Annapurna Diaz, Adolfo Pang, Yifan Desai, Parth Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis |
| title | Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis |
| title_full | Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis |
| title_fullStr | Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis |
| title_full_unstemmed | Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis |
| title_short | Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis |
| title_sort | severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248092/ https://www.ncbi.nlm.nih.gov/pubmed/36375041 http://dx.doi.org/10.1182/bloodadvances.2022008968 |
| work_keys_str_mv | AT sharmaparth severeautoimmuneintravascularhemolyticanemiainpatientsreceivingalemtuzumabformultiplesclerosis AT saksenaannapurna severeautoimmuneintravascularhemolyticanemiainpatientsreceivingalemtuzumabformultiplesclerosis AT diazadolfo severeautoimmuneintravascularhemolyticanemiainpatientsreceivingalemtuzumabformultiplesclerosis AT pangyifan severeautoimmuneintravascularhemolyticanemiainpatientsreceivingalemtuzumabformultiplesclerosis AT desaiparth severeautoimmuneintravascularhemolyticanemiainpatientsreceivingalemtuzumabformultiplesclerosis |